Approval · Notice of Compliance 2585 · 2001
SSD: Notice of Compliance 2585
Issued May 30, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2585
- Date
- May 30, 2001
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in manufacturer's name
- Therapeutic class
- Topical antibacterial agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SSD | 02170310 | Cancelled Post Market |
Medicinal ingredients
- SILVER SULFADIAZINE 1 PER